UCSF Pain Summit Multidisciplinary Approach to Acute and Chronic Pain

Similar documents
SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP)

Subject: Pain Management (Page 1 of 7)

Knock Out Opioid Abuse in New Jersey:

New Guidelines for Prescribing Opioids for Chronic Pain

GUIDELINEs ON PAIN MANAGEMENT IN UROLOGY

Brief Pain Surveys. Developed by: Betty R. Ferrell, PhD, FAAN and Margo McCaffery RN, MSN, FAAN

Rule Governing the Prescribing of Opioids for Pain

Cancer Pain: A Clinical Overview. Linda A. King, MD Section of Palliative Care and Medical Ethics

Palliative and Hospice Care of the Terminally Ill Introduction

Universal Precautions and Opioid Risk. Assessment. Questions: How often do you screen your patients for risk of misuse when prescribing opioids?

Prior Authorization Guideline

Overview of Essentials of Pain Management. Updated 11/2016

Opioid Review and MAT Clinic CDC Guidelines

UCSF Pediatric Hospital Medicine Boot Camp Pain Session 6/21/14. Cynthia Kim and Stephen Wilson

SCOPING DOCUMENT FOR WHO Treatment Guidelines on pain related to cancer, HIV and other progressive life-threatening illnesses in adults

Guidelines for Management of Chronic Non- Malignant Pain

Standard of Practice for Prescribing Opioids (Excluding Cancer, Palliative, and End-of-Life Care)

GUIDELINES AND AUDIT IMPLEMENTATION NETWORK

Analgesics: Management of Pain In the Elderly Handout Package

Victoria L. Thornton, MD, MBA Consulting Associate Duke University School of Nursing. Sickle Cell Disease: Breaking Down the Myths and Barriers

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

Pain Management at Stony Brook Medicine

An unpleasant sensory and emotional experience associated with actual or potential tissue damage.

Welcome - we will begin the webinar shortly Please read the participation tips below:

MORPHINE ADMINISTRATION

Opiate Use Disorder and Opiate Overdose

Wisconsin Opioid Prescribing Guideline Draft Scope and purpose of the guideline

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Section I. Short-acting opioid Prior Authorization Criteria

5/9/2013. Children who require chronic opioids for chronic pain are at significant risk of developing opioid addiction?

Equianalgesic Dosing: Making Opioid Interchange Easier. Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine

Agenda. Case Discussions. Managing Acute & Chronic Pain (requiring opioid analgesics) in Patients on MAT. Daniel Alford, MD Disclosures

Opioid Conversion Guidelines

Opioid Management of Chronic (Non- Cancer) Pain

STARTER PACK: Webinar #1 ADE4 - OPIOIDS

I. Chronic Pain Information Page 2-3. II. The Role of the Primary Care Physician in Chronic Pain Management Page 3-4

Intractable pain syndrome is defined as persistent pain despite all the reasonable efforts to treat.

Learning Objectives. Perioperative goals. Acute Pain in the Chronic Pain Patient for Ambulatory Surgery 9/8/16

Opioids in the Management of Chronic Pain: An Overview

What is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls?

SAFE PRESCRIBING: RULES AND REGULATIONS. Michelle Y. Owens, MD MS State Board of Medical Licensure June 30, 2017

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

Pain Management in the Elderly. Martha Watson, MS, APRN, GCNS Christie Bowser, RN-BC, RN

Opioid Overdose Best Practices Guideline. Table of Contents. A. General description: B: Typical signs and symptoms:

Management of Pain - A Comparison of Current Guidelines

(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines)

WHEN LESS IS MORE REDUCING OPIOID OVERPRESCRIBING

Ethics Issue for Today

Pain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN

Responding to The Joint Commission Alert on Safe Use of Opioids in Hospitals

Pain management in Paediatric Palliative Care. Dr Jane Nakawesi 14 th August 2017

Digital RIC. Rhode Island College. Linda M. Green Rhode Island College

16 year old with Disabling Chest Wall Pain after Thoracoscopic Talc Pleurodesis for Treatment of Recurrent Spontaneous Pneumothoraces

PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST

Review of Pain Management with Clinical and Regulatory Updates

OPIOIDS: THE GOOD, THE BAD, AND EVERYTHING IN-BETWEEN

Fighting the Good Fight: How to Convert Opioids Just Right!

Vermont. Prescribing and Dispensing Profile. Research current through November 2015.

Treatment of Pain in an Emergent Setting

July We hope that our tool will be a useful aid in your efforts to improve pain management in your setting. Sincerely, 7/14

GUIDELINES ON PAIN MANAGEMENT IN UROLOGY

CDC Guideline for Prescribing Opioids for Chronic Pain. Centers for Disease Control and Prevention National Center for Injury Prevention and Control

Pain Management: Overview of A Practical Approach

Effective Postoperative Pain Management for Children. Nancy L. Glass, MD, MBA,

THE EAPC OPIOID GUIDELINES: PROCESS, RESULTS AND FUTURE DEVELOPMENT

Managing Pain in Individuals with Serious Illness and Comorbid Substance Use Disorder

E-Learning Module N: Pharmacological Review

disease or in clients who consume alcohol on a regular basis. bilirubin

PAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose

Acute pain management in opioid tolerant patients. Muhammad Laklouk

Po dilaudid versus iv dilaudid

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.

Prescribing drugs of dependence in general practice, Part C

ROTATION SUMMARY PEDIATRIC PAIN MANAGEMENT

Current evidence in acute pain management. Jeremy Cashman

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Pharmacist s Role In Pain Management. Katrina Lynn, Pharm D PSHP Annual Assembly: October 12, 2017

Treating Pain in Pediatrics: Safety First. Nicole Ralston, RN Jamie Sperduto, RN, BSN

Practical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR

PAIN MANAGEMENT IN UROLOGY

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division

OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES

Objectives: What is your Definition of Pain? 8/16/2017

UCSD DEPARTMENT OF ANESTHESIOLOGY

NYSPFP Kickoff. Reducing Adverse Drug Events from Opioids. April 6, 2017

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Satisfactory Analgesia Minimal Emesis in Day Surgeries. (SAME-Day study) A Randomized Control Trial Comparing Morphine and Hydromorphone

The Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010

Care of the Dying Management in Severe Renal Failure

Scope of the Opiate Problem 6/5/18. Chronic Pain Management and the Use of Opioid Medications: The CDC Guideline and Beyond. Overview.

Index. Note: Page numbers of article titles are in boldface type.

MAT for Opioid Dependence. MAT and Pain Management. Epidemiology. Epidemiology. Factors Impacting Pain Perception 9/23/2014

Fact Sheet. Zohydro ER (hydrocodone bitartrate) Extended-Release Capsules, CII

Strategies for Managing Pain and Suffering (and a bit about palliative care)

Care of the Dying Management in Severe Renal Failure

Methadone Maintenance

Transcription:

Multidisciplinary Approach to Acute and Chronic Pain UCSF NIH Center of Excellence in Pain Education (CoEPE) UCSF Pain Research Group May 16, 2013, 8:30am-3:30pm Millberry Union, City Lights and Golden Gate Rooms Pre and Post Test (Answers) 1. Which of the following is NOT a known risk factor for opioid overdose or misuse? a. History of a substance use disorder b. Untreated depression c. Female gender d. Tobacco use e. White race The answer is C. a. A personal history of substance use disorder is one of the strongest risk factors for opioid overdose and should be considered a relative contraindication to prescribing opioids. Patients with a history of substance use disorders should be very closely supported and monitored if they are started on controlled substances. Close supervision would include: support from a behavioral health specialist or a relapse prevention group; short prescription lengths (i.e. 2 weeks to begin with) and frequent medical visits; frequent urine drug testing; pill counts to assess for diversion; regular use of the statewide Prescription Drug Monitoring Program (PDMP); and use of a clear patient-provider agreement. Patients with a personal history of opioid misuse are at particularly high risk. In these patients, opioids for chronic pain are a very last resort and require very close monitoring. b. Untreated depression is also a risk factor for opioid misuse and for overdose. Patients with anxiety, bipolar disorder, depression, PTSD, ADHD and psychotic disorders are all at elevated risk for misuse and overdose. It is believed that this elevation in risk is multifactorial. Often, patients use opioids to self-medicate for these disorders and are more prone to

overdose because of dose escalation during periods of psychological distress. For the same reason, their risk of developing psychological dependence is increased. These populations are generally at increased risk for all substance use disorders. Additionally, they are at increased risk for intentional overdose. c. Female gender is not a risk factor for opioid overdose or misuse. In fact, male patients are at higher risk than female patients of opioid misuse and overdose. Other evidence based risk factors for overdose or misuse include: age less than 45; concurrent heavy alcohol use; concurrent tobacco use; mental health disorders including depression, bipolar disorder, PTSD, and ADHD; history of more than 5 prescribers in one year; more than 50% increase in dose over 2 months; a history of requesting one or more early refills; combined prescription of benzodiazepines; use by non-medical routes (e.g. intranasal or injected); and concurrent use of illicit substances, especially cocaine. d. Tobacco use: like other substance use disorders, tobacco use disorder is correlated with higher rates of opioid misuse and, relatedly, overdose. e. In both national and local studies, White race is associated with increased risk of prescription opioid misuse when compared to African American or Asian race. In studies of medical provider perception, medical providers are more likely to predict that African American patients are misusing opioids than White patients. In these same populations, White patients are in fact more likely to be misusing their opioid prescriptions. 2. When treating pain in the pediatric population, which of the following is true? a. Infants and children exhibit pharmacokinetics similar to adults except they are smaller so weight based dosing should be applied. b. It is easier to assess pain in infants and children because they more readily verbalize their degree of pain. c. A multimodal approach to pain management in children may include integrative therapies, adjuvant medications and opiates. d. Children rarely respond to behavioral therapies for pain management. e. Mind-body techniques are most effective in children if introduced during an acute pain crisis. The answer is C. A multimodal approach to pain management in children may include a variety of different therapies ranging from integrative modalities such as acupuncture and biofeedback, to opioid-sparing medications, opioids, and potentially interventional techniques. Infants and children do not exhibit the same pharmacokinetics as adults. Pain assessment in children can be more difficult due to their behavioral and developmental stage. Children can be extremely amenable to behavioral therapies and mind-body techniques as they have a

natural developmental drive for mastery and autonomy. Mind-body techniques are more likely to be successful if introduced during a non-acute phase of an illness. 3. Which of the following are considered safety strategies for patients receiving patient-controlled analgesia? a. Using concurrent opioids via different routes b. Extending the dosing lockout interval c. Using hydromorphone as opioid of choice d. Assessing institutional use of naloxone The answer is B. Both morphine and hydromorphone may not peak in serum concentration until 15-20 minutes after each bolus dose. If a patient continues to receive PCA doses before previous doses have peaked, they could unintentionally overdose themselves, leading to sedation or the need for naloxone rescue. To avoid this, a PCA pump is programmed with a lockout interval determined by the provider. Best practice standards recommend conservative initial dosing parameters for PCA, including a 10-minute lockout interval, which could be increased to 15 minutes in high-risk patients. In a UCSFMC pilot study, increasing the PCA lockout to 10 minute standard did not inadvertently decrease the safety or quality of pain control delivered to the patients receiving PCA. Using concurrent different routes has the potential to decrease safety as each route has its own time for peak effect. In UCSFMC studies use of PCA hydromorphone was associated with an increased need for rescue naloxone compared with morphine. Although assessment of naloxone use is important in determining which areas need further improvement, mere assessment is only the first step in developing safer strategies for patient opioid use. 4. According to the 2009 American Pain Society practice guidelines for the treatment of low back pain, intensive interdisciplinary rehabilitation with a cognitive-behavioral emphasis is strongly recommended for patients with: a. Acute low back pain b. Chronic low back pain and depression c. Radicular low back pain who are being considered for surgery d. Nonradicular low back pain who have not responded to usual, noninterdisciplinary interventions e. All of the above The answer is D.

The 2009 APS guidelines state in Recommendation 2, In patients with nonradicular low back pain who do not respond to usual, non interdisciplinary interventions, it is recommended that clinicians consider intensive interdisciplinary rehabilitation with a cognitive/behavioral emphasis (strong recommendation, high-quality evidence). Chronic back pain is a complex condition that involves biologic, psychological, and environmental factors. For patients with persistent and disabling back pain despite recommended noninterdisciplinary therapies, clinicians should counsel patients about interdisciplinary rehabilitation (defined as an integrated intervention with rehabilitation plus a psychological and/or social/occupational component) as a treatment option. Reference: Chou R, et al. Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: an evidence-based clinical practice guideline from the American Pain Society. Spine (Phila Pa 1976). 2009 May 1;34(10):1066-77. 5. Which of the following is not a standard management strategy before surgical intervention for abdominal pain resulting from chronic pancreatitis? a. Extracorporeal shock wave lithotripsy (ESWL) for pancreatic stones b. ERCP to stent pancreatic ductal strictures and remove pancreatic calculi c. A step up approach for the treatment of intractable pain d. Extracorporeal shock wave lithotripsy (ESWL) for gallstones e. Assessment for possible endocrine insufficiency after total pancreatectomy The answer is D. A number of endoscopic and medical management options exist for the pain associated with acute pancreatitis. These include ESWL of pancreatic stones to facilitate endoscopic extraction, ERCP to stent associated pancreatic ductal strictures, and a conservative step up approach before proceeding to endoscopy. Surgical strategies for the treatment of pain in chronic pancreatitis can be categorized into three major groups: drainage procedures, procedures combining drainage and resection, and resectional procedures. To reduce the incidence of brittle diabetes after total pancreatectomy, interest in the addition of islet autotransplantation has been renewed---further studies are necessary to determine efficacy. The most frequent cause of chronic pancreatitis is alcohol toxicity. In addition, a genetic predisposition such as cystic fibrosis, uses of certain types of medication, anatomic abnormalities, and autoimmunity can play a role. Biliary tract disease and gallstones are a less frequent cause of chronic pancreatitis,

and while a cholecystectomy could play an important role in the prevention of recurrent acute pancreatitis, neither cholecystectomy nor extracorporal shock wave lithotripsy for gallstones would be utilized as the principal modality for the chronic pain symptoms associated with the condition. Reference: Issa Y, van Santvoort HC, van Goor H, Cahen DL, Bruno MJ, Boermeester MA. Surgical and Endoscopic Treatment of Pain in Chronic Pancreatitis: A Multidisciplinary Update. Dig Surg 2013; 30:35-50. 6. Which of the following is NOT included in the UCSF Pain Assessment hierarchy? a. Self Report b. Behaviors c. Individual Patient Pain Tolerance d. Physiologic Measures e. Assume Pain Present The answer is C. 7. Which of the following is NOT currently a resource for pain management at UCSF? a. IP3 (Integrated Pediatric Pain and Palliative Care Service) b. UCSF Helen Diller Family Comprehensive Cancer Center - Symptom Management Service c. Inpatient Center for the Management of Chronic Pain and Addiction d. Pain Management Center (PMC) Mount Zion e. Osher Center for Integrative Medicine The answer is C. UCSF Pain Management Resources include: Anesthesia Pain Medicine Services: o Pain Management Center o Inpatient Acute Pain Service o Inpatient Chronic Pain Consult Service Clinical Pharmacy Emergency Medicine Hematology/Oncology Integrated Pediatric Pain and Palliative Care Service (IP3) Medicine o Genomic Medicine o Hospital Medicine o Palliative Medicine o Rheumatology Clinic Neurology Neurosurgery OB/Gyn Pelvic Pain Oral and Maxillofacial Surgery Orthopedic Surgery

Osher Center for Integrative Medicine Otolaryngology Physical Therapy/Rehab Radiology Urology 8. Multimodal Analgesia at UCSF can be described by all the following except? a. Ordering Morphine for moderate pain and Hydromorphone (Dilaudid) for severe pain. b. Ordering scheduled doses of acetaminophen (PO/IV) plus Morphine as needed for severe break through pain. c. Ordering a combination of an oral analgesic plus a peripheral nerve catheter infusion of local anesthetics d. Ordering a combination of analgesics that act on different pathways such as acetaminophen, gabapentin and celecoxib. e. Combining acupuncture with scheduled doses of acetaminophen and ibuprofen. The answer is A. Ordering practices may reveal the use of a single opioid, but given at a low dose for the treatment of moderate pain and a higher dose for severe pain. Although not supported by evidence, a review of practices also reveals the use of Hydromorphone (Dilaudid) for severe pain often following the use of Morphine. Rotation from one opioid to another may result in superior analgesia however, use of two different opioids does not constitute a different modality (opioids). However, the combined use of an opioid (Morphine) with a non opioid such as acetaminophen, that is known to reduce opioid requirements, has been shown to be an effective analgesic strategy. Multimodal analgesia may also include other strategies such as combining an oral pharmacologic analgesics with administration of local anesthetics to specific nerves and the inclusion of non pharmacologic approaches such as acupuncture / mind body techniques. The combination of several non-opioid analgesics administered in a schedule has increasingly been shown to direct significant analgesia and at times minimize or eliminate opioid requirements especially in the perioperative domain. Although such strategies can avoid or reduce opioid associated adverse side effects such as respiratory depression, they can be (rarely) associated with other types of risks, such as CAD, Renal and hepatic toxicity. 9. In 2012 the WHO Guidelines on the pharmacological treatment of persisting pain in children with medical illness were published: Four pharmacological principles were recommended to achieve good analgesia in children with cancer or other persistent pain specific to situations with tissue damage where there is a clear role for pharmacological treatment.

Which of the following statement regarding the 2012 WHO Guideline is correct: a. According to the WHO Pain Ladder Step 2, codeine is appropriate for mild-to-medium pain, if acetaminophen and ibuprofen are not effective. b. Medications should be administered to children by the fastest and most effective route, making intravenous formulations the preferred route of administration. c. Opioid dosing to effect, i.e. on an as-needed ( PRN ) basis should be the preferred modality of administration. d. Pharmacological treatment should be tailored to the individual disease and opioid analgesics should be titrated following fixed guidelines. e. The WHO recommends 2 steps: acetaminophen and ibuprofen for mild pain and morphine for medium-severe pain. The answer is E. It is recommended by the WHO to use the analgesic treatment in two steps according to the child s level of pain severity. Acetaminophen and ibuprofen are the medicines of choice in the first step (mild pain). If pain severity associated with a medical illness is assessed as moderate or severe, the administration of a strong opioid is necessary. Morphine is the medicine of choice for the second step, although other strong opioids should be considered and made available to ensure an alternative to morphine in case of intolerable side-effects. The decision to prescribe and administer opioid analgesics bypassing the first step should be based on a clinical judgement of the severity of a child s pain, on careful considerations of the disability caused by pain, on the cause of the pain, and expected prognosis and other aspects. The use of codeine is not recommended anymore. a. In 2012 the WHO recommendations changed from a three-step pain ladder (the now obsolete middle step was weak opioids such as codeine ) to a two-step strategy for the treatment of persisting pain in children with medical illness. Codeine is a weaker analgesic than commonly believed and ineffective a large number of children (up to 36%). Furthermore, approximately 5% of white Caucasians (29% of Ethopians) have multiple copies of the enzyme CYP 2D6, are ultra rapid metabolizers, and as a result therefore metabolize unusually high doses of morphine. Pediatric deaths due to codeine at recommended dosing have been published. b. Medications should be administered to children by the simplest, most effective and least painful route, making oral formulations the most convenient and least expensive route of administration. If possible, the route of administration should be chosen by the child. Painful

intramuscular administration of pain medication is unnecessary and obsolete. Novel Routes usually make use of high liphophilicity of certain opioids to cross skin or mucosa. c. When pain is constantly present, analgesics should be administered, while monitoring side-effects, at regular intervals (by the clock and NOT as an as needed basis). Regular scheduling ensures a steady blood level, reducing the peaks and troughs of PRN ( as needed ) dosing. PRN only (without scheduled analgesia) may take several hours and higher opioid doses to relieve pain and results in cycle of under medication and pain, alternating with periods of over medication and drug toxicity. d. The WHO Principles state, that the treatment should be tailored to the individual child and opioid analgesics should be titrated on an individual basis. 10. Which of the following statements regarding acute, chronic and neuropathic pain is NOT correct? a. "Chronic Pain" in children usually is defined as "pain beyond the expected time of healing" and in adults usually as "pain lasting longer than 3 months" b. There is reasonable evidence for the administration of opioids to treat patients with chronic pain conditions such as fibromyalgia, chronic musculoskeletal pain, functional abdominal pain, headaches/migraines c. The administration of codeine (e.g. Tylenol #3) and meperidine (e.g. Demerol) is NOT recommend in the treatment of acute pain conditions d. First line adjuvant analgesia for neuropathic pain include low-dose tricyclic antidepressants and gabapentinoids e. The choice of an analgesic does NOT depend on the pain score The answer is B. There is NO evidence for the administration of opioids to treat patients with chronic pain conditions such as fibromyalgia, chronic musculoskeletal pain, functional abdominal pain, headaches/migraines, in fact their use would be considered contraindicated by most pain specialists in the US.